Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES LANTMÄNNEN IN CONNECTION WITH ISSUE OF PARTICIPATING DEBENTURES
Mandate

VINGE ADVISES LANTMÄNNEN IN CONNECTION WITH ISSUE OF PARTICIPATING DEBENTURES

November 14, 2014

Lantmännen co-operative association has published a prospectus in relation to an offer to subscribe for participating debentures. The offer, which amounts to a maximum amount of SEK 250 million, is primarily directed to Lantmännen’s members and full-time group employees in Sweden and a number of associations in the agricultural and food industry. Vinge advised Lantmännen in connection with the offer.

Vinge’s team consisted of partner Jesper Schönbeck and associates Joakim Hagberg, Tora Hansjons and Nils Fredrik Dehlin.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

 Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024